Exciting times at Sandoz! 🙌 Today marks a major milestone as Sandoz completes the strategic acquisition of Just-Evotec Biologics EU SAS in Toulouse, further consolidating our leadership in biosimil...
AI: Completed strategic acquisition of Just-Evotec Biologics EU SAS in Toulouse. Expands in-house biosimilar development and manufacturing capabilities targeting USD 300+ billion LoE market opportunity. Multiple executives on-site, specific facility location, clear strategic rationale.